Broadhurst Vanessa's most recent trade in Zoetis Inc - Ordinary Shares - Class A was a trade of 1,596 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Zoetis | Vanessa Broadhurst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 1,596 | 1,596 | - | - | Restricted Stock Unit | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 25,538 | 25,538 | - | - | Employee Stock Options (Right to Buy) | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 1,576 | 1,576 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,910 | 24,591 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,910 | 0 | - | - | Performance Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,830 | 0 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,830 | 21,921 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 997 | 23,594 (0%) | 0% | 156.7 | 156,240 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 574 | 21,347 (0%) | 0% | 156.7 | 89,952 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 492 | 21,839 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 492 | 983 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 408 | 20,242 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 408 | 408 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.15 per share. | 13 Feb 2025 | 158 | 21,681 (0%) | 0% | 156.2 | 24,672 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 155.26 per share. | 13 Feb 2025 | 151 | 20,091 (0%) | 0% | 155.3 | 23,444 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,910 | 2,910 | - | - | Performance Share Units | |
Zoetis | Vanessa Broadhurst | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 0 | - | - | Restricted Stock Unit | |
Zoetis | Vanessa Broadhurst | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 2,252 (0%) | 0% | - | Common Stock | |
Zoetis | Vanessa Broadhurst | Director | Other type of transaction at price $ 174.12 per share. | 06 Feb 2025 | 395 | 1,857 (0%) | 0% | 174.1 | 68,777 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 9,809 | 0 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 9,809 | 24,852 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.16 per share. | 08 Jul 2024 | 5,018 | 19,834 (0%) | 0% | 147.2 | 738,449 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Sale of securities on an exchange or to another person at price $ 162.16 per share. | 13 Mar 2024 | 8,891 | 15,043 (0%) | 0% | 162.2 | 1,441,765 | Common Stock |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 23,745 | 23,745 | - | - | Employee Stock Options (Right to Buy) | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 1,475 | 1,475 | - | - | Restricted Share Units | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 408 | 24,143 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 408 | 816 | - | - | Restricted Share Units | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.85 per share. | 13 Feb 2024 | 209 | 23,934 (0%) | 0% | 157.9 | 32,991 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 4,701 | 0 | - | - | Performance Share Units | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 4,701 | 25,081 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.40 per share. | 12 Feb 2024 | 2,136 | 23,735 (0%) | 0% | 157.4 | 336,206 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 790 | 25,871 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,880 | 21,083 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,880 | 0 | - | - | Restricted Share Units | |
Zoetis | Vanessa Broadhurst | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 1,493 (0%) | 0% | - | Common Stock | |
Zoetis | Broadhurst Vanessa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 0 | - | - | Restricted Stock Unit | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.33 per share. | 08 Feb 2024 | 703 | 20,380 (0%) | 0% | 156.3 | 109,900 | Common Stock |
Zoetis | Broadhurst Vanessa | Director | Other type of transaction at price $ 195.75 per share. | 08 Feb 2024 | 477 | 1,016 (0%) | 0% | 195.8 | 93,373 | Common Stock |
Zoetis | Broadhurst Vanessa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,223 | 1,223 | - | - | Restricted Stock Unit | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 20,263 | 20,263 | - | - | Employee Stock Options (Right to Buy) | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,981 | 20,643 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.01 per share. | 13 Feb 2023 | 1,440 | 19,203 (0%) | 0% | 162.0 | 233,294 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,224 | 1,224 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,592 | 17,259 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,592 | 0 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.08 per share. | 10 Feb 2023 | 597 | 16,662 (0%) | 0% | 162.1 | 96,762 | Common Stock |
Zoetis | Vanessa Broadhurst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 1,480 | 1,480 | - | - | Restricted Stock Unit | |
Zoetis | Vanessa Broadhurst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 1,370 | 1,370 | - | - | Restricted Stock Unit | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 18,077 | 18,077 | - | - | Employee Stock Options (Right to Buy) | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,557 | 244 | - | - | Performance Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,557 | 16,592 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,451 | 14,937 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 2,451 | 0 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 1,830 | 1,830 | - | - | Restricted Share Units | |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.89 per share. | 14 Feb 2022 | 925 | 15,667 (0%) | 0% | 165.9 | 153,448 | Common Stock |
Johnson & Johnson | Vanessa Broadhurst | EVP, Global Corp Aff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.85 per share. | 14 Feb 2022 | 902 | 14,035 (0%) | 0% | 168.9 | 152,303 | Common Stock |